LENZ Therapeutics Statistics
Total Valuation
LENZ has a market cap or net worth of $401.39 million. The enterprise value is $215.89 million.
| Market Cap | 401.39M |
| Enterprise Value | 215.89M |
Important Dates
The next estimated earnings date is Sunday, May 26, 2024, before market open.
| Earnings Date | May 26, 2024 |
| Ex-Dividend Date | Mar 22, 2024 |
Share Statistics
LENZ has 25.53 million shares outstanding. The number of shares has increased by 3.90% in one year.
| Shares Outstanding | 25.53M |
| Shares Change (YoY) | +3.90% |
| Shares Change (QoQ) | +0.97% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.19 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 39.20, with a Debt / Equity ratio of 0.00.
| Current Ratio | 39.20 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.20% and return on invested capital (ROIC) is -73.50%.
| Return on Equity (ROE) | -56.20% |
| Return on Assets (ROA) | -47.40% |
| Return on Capital (ROIC) | -73.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.09% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -23.09% |
| 50-Day Moving Average | 20.73 |
| 200-Day Moving Average | 18.26 |
| Relative Strength Index (RSI) | 33.11 |
| Average Volume (30 Days) | 253,649 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -135.19M |
| Pretax Income | -124.65M |
| Net Income | -124.65M |
| EBITDA | -117.96M |
| EBIT | -124.65M |
| Earnings Per Share (EPS) | -$15.33 |
Balance Sheet
The company has $185.86 million in cash and $362,000 in debt, giving a net cash position of $185.50 million or $7.26 per share.
| Cash & Cash Equivalents | 185.86M |
| Total Debt | 362,000 |
| Net Cash | 185.50M |
| Net Cash Per Share | $7.26 |
| Equity / Book Value | 183.58M |
| Book Value Per Share | 7.19 |
| Working Capital | 183.22M |
Cash Flow
In the last 12 months, operating cash flow was -$90.01 million and capital expenditures -$8.95 million, giving a free cash flow of -$98.96 million.
| Operating Cash Flow | -90.01M |
| Capital Expenditures | -8.95M |
| Free Cash Flow | -98.96M |
| FCF Per Share | -$12.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $7.21, which amounts to a dividend yield of 45.87%.
| Dividend Per Share | $7.21 |
| Dividend Yield | 45.87% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.90% |
| Shareholder Yield | 41.96% |
| Earnings Yield | -31.06% |
| FCF Yield | -24.65% |
Analyst Forecast
The average price target for LENZ is $31.33, which is 99.30% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.33 |
| Price Target Difference | 99.30% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |